Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics()()

Combination chemotherapy with gemcitabine and cisplatin in patients with metastatic urothelial cancer of the bladder frequently results in the development of acquired drug resistance. Availability of cell culture models with acquired resistance could help to identify candidate treatments for an effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallo, Stefan, Michaelis, Martin, Rothweiler, Florian, Bartsch, Georg, Gust, Kilian M., Limbart, Dominik M., Rödel, Franz, Wezel, Felix, Haferkamp, Axel, Cinatl, Jindrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487788/
https://www.ncbi.nlm.nih.gov/pubmed/26055179
http://dx.doi.org/10.1016/j.tranon.2015.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487788/
https://www.ncbi.nlm.nih.gov/pubmed/26055179
http://dx.doi.org/10.1016/j.tranon.2015.04.002

Ejemplares similares